Granulocyte Colony Stimulating Factor Increases the Efficacy of Conventional Amphotericin in the Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients following Intensive Chemotherapy or Bone Marrow Transplantation for Haematological Malignancies

References

• Bodey, G. P. and Anaissie, E. J. (1989). Opportunistic fungal infections: A major problem in immunocompromised patients; In Opportunistic Fungal Infections: Focus on Fluconazole. Richardson, R. G. (ed). Royal Society of Medicine Services, London, 1–16.
   Google Scholar
• Bodey, G. P. (1986). Fungal infection and fever of unknown origin in neutropenic patients. Am J Med, 80(5C), 112–119.
   PubMed Web of Science ®Google Scholar
• Maksymiuk, A. W., Thongprasert, S., Hopfer, R., Luna, M., Fainstein, V. and Bodey, G. P. (1984). Systemic Candidiasis in cancer patients. Am J Med, 77(4D), 20–27.
   PubMed Web of Science ®Google Scholar
• Pizzo, P. A. (1993). Management of fever in patients with cancer and treatment induced neutropenia. N Engl J Med, 328, 1323–1332.
   PubMed Web of Science ®Google Scholar
• Prentice, H. G., Hann, I. M., Herbrecht, R., Aoun, M., Kvaloy, S., Catovsky, D., et al. (1997). A randomised comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. Br J Haematol, 98, 711–718.
   PubMed Web of Science ®Google Scholar
• Lister, J. (1996). Amphotericin B Lipid Complex (Abelcet) in the treatment of invasive mycoses: the North American experience. Eur J Haematol, 56(57), 18–23.
   Google Scholar
• Mehta, J., Kelsey, S., Chu, P., Powles, R., Hazel, D., Riley, U., et al. (1997). Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with haematologic malignancies. Bone Marrow Transplant, 20, 39–43.
   PubMed Web of Science ®Google Scholar
• Mills, W., Chopra, R., Linch, D. C. and Goldstone, A. H. (1994). Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. British Journal of Haematology, 86(4), 754–760.
   PubMed Web of Science ®Google Scholar
• Ohno, R., Tomonaga, M., Kobayashi, T., Kanamura, A., Shirakawa, S., Matsuoka, T., et al. (1990). Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukaemia. N Engl J Med, 323(13), 871–877.
   PubMed Web of Science ®Google Scholar
• Crawford, J., Ozer, H., Stoller, R., Johnson, D., Lyman, G., Tabbara, I., et al. (1991). Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Med, 325, 164–170.
   PubMed Web of Science ®Google Scholar
• Nemunaitis, J., Rabinowe, S. N., Singer, J. W., Bierman, P. J., Vose, J. M., Freedman, A. S., et al. (1991). Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med, 324, 1773–1778.
   PubMed Web of Science ®Google Scholar
• Heil, G., Hoezler, D., Sanz, M. A., Lechner, K., Liu Yin, J. A., Papa, G., et al. (1997). A randomised, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukaemia. Blood, 90(12), 4710–4718.
   PubMed Web of Science ®Google Scholar
• Roilides, E., Holmes, A., Blake, C., Pizzo, P. A. and Walsh, T. J. (1995). Effects of granulocyte colony stimulating factor and interferon-gamma on antifungal activity of human polymorphonuclear neutrophils against pseudohyphae of different medically important Candida species. J Leukoc Biol, 57(4), 651–656.
   PubMed Web of Science ®Google Scholar
• Vecchiarelli, A., Monari, C., Baldelli, F., Pietrella, D., Retini, C., Francisci, D., et al. (1995). Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J Infect Dis, 171(6), 1448–1454.
   PubMed Web of Science ®Google Scholar
• Liles, W. C., Huang, J. E., van-Burik, J. H., Bowden, R. A. and Dale, D. C. (1997). Granulocyte colony stimulating factor administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis, 175, 1012–1015.
   PubMed Web of Science ®Google Scholar
• Richardson, M. D., Brownlie, C. E. D. and Shankland, G. S. (1992). Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils. J Med Vet Mycol, 30, 433–441.
   PubMedGoogle Scholar
• Williams, M. A., Kelsey, S. M., Collins, P. W., Gutteridge, C. N. and Newland, A. C. (1995). Administration of rHuGM-CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high dose chemotherapy. Br J Haematol, 90, 31–40.
   PubMed Web of Science ®Google Scholar
• Wang, M., Friedman, H. and Djeu, J. Y. (1989). Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors: IL-3, GM-CSF and M-CSF. J Immunol, 2, 671–677.
   Google Scholar
• Matsumoto, M., Matsubara, S., Matsuno, T., Tamura, M., Hattori, K., Nomura, H., et al. (1987). Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun, 55(11), 2715–2720.
   PubMed Web of Science ®Google Scholar
• Aviles, A., Guzman, R., Garcia, E. L., Talavera, A. and Diaz-Maqueo, J. C. (1996). Results of a randomized trial of granulocyte colony-stimulating factor in patients with infection and severe granulocytopenia. Anticancer Drugs, 7(4), 392–7.
   PubMed Web of Science ®Google Scholar
• Peters, B. G., Adkins, D. R., Harrison, B. R., Velasquez, W. S., Dunphy, F. R., Petruska, P. J., et al. (1996). Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis. Bone Marrow Transplant, 18, 93–102.
   PubMed Web of Science ®Google Scholar
• Fukushima, T., Sumazaki, R., Shibasaki, M., Saitoh, H., Fujiyaki, Y., Kaneka, M., et al. (1995). Successful treatment of invasive thoracopulmonary mucormycosis in a patient with acute lymphoblastic leukaemia. Cancer, 76(5), 895–899.
   PubMed Web of Science ®Google Scholar
• Muranaka, H., Suga, M., Nakagawa, Sato, K., Gushima, Y. and Ando, M. (1997). Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenia murine model of trichosporonosis. Infect Immun, 65(8), 3422–3429.
   PubMed Web of Science ®Google Scholar
• Roilides, E., Uhlig, K., Vernon, D., Pizzo, P. A. and Walsh, T. J. (1992). Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma. J Infect Dis, 166(3), 668–673.
   PubMed Web of Science ®Google Scholar
• Natarajan, U., Brummer, E. and Stevens, D. A. (1997). Effect of granulocyte colony-stimulating factor on the candidacidal activity of polymorphonuclear neutrophils and their collaboration with fluconazole. Antimicrob Agents Chemother, 41(7), 1575–1578.
   PubMed Web of Science ®Google Scholar
• Dignani, M. C., Anaissie, E. J., Hester, J. P., O'Brien, S., Vartivarian, S. E., Rex, J. H., et al. (1997). Treatment of neutropenia-related fungal infections with granulocyte colony stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia, 11(10), 1621–1630.
   PubMed Web of Science ®Google Scholar
• Hester, J. P., Dignani, M. C., Anaissie, E. J., Kantarjian, H. M., O'Brien, S. and Freireich, E. J. (1995). Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosupressed patients with established infection. J Clin Apheresis, 10(4), 188–193.
   PubMed Web of Science ®Google Scholar
• Richardson, M. D. and Kokki, M. H. (1998). Antifungal therapy in bone marrow failure. Br J Haematol, 100, 619–628.
   PubMed Web of Science ®Google Scholar